Patent ID: 11872269
Assignee: SIWA CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 6:
7. A method of treating a subject with sarcopenia, comprising:
administering a first immunogenic composition comprising a first AGE-modified protein and a first adjuvant; and
administering a second immunogenic composition comprising a second AGE-modified protein and a second adjuvant;
wherein the second AGE-modified protein is different from the first AGE-modified protein,
the first AGE-modified protein comprises a carboxymethyllysine-modified protein,
the second AGE-modified protein comprises a carboxyethyllysine-modified protein, and
the first adjuvant and the second adjuvant are each independently selected from the group consisting of aluminum salts, oil emulsions, bacterial products, liposomes, and immunostimulating complexes.